Skip to content

Pharma manufacturers at Risk of Increased Liability Exposures

Samantha Silver and Charlie Whitchurch from global law firm Kennedys explore some of the key legislative developments that will impact manufacturers operating in the life sciences sector as they enter 2024 for EPM.

Pharma manufacturers at Risk of Increased Liability Exposures
Published: | 6 min read

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information